XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid In Capital
Cumulative Net Income
Cumulative Other Comprehensive Loss
Cumulative Common Distributions
Balance (in shares) at Dec. 31, 2019   48,201,941        
Beginning balance at Dec. 31, 2019 $ 1,705,754 $ 482 $ 2,612,425 $ 177,217 $ (200) $ (1,084,170)
Increase (Decrease) in Shareholders' Equity            
Share grants (in shares)   0        
Share grants 379   379      
Share repurchases (in shares)   (1,012)        
Share repurchases (27)   (27)      
Net current period other comprehensive income (loss) (61)       (61)  
Net income (loss) 10,840     10,840    
Distributions to common shareholders (26,511)         (26,511)
Balance (in shares) at Mar. 31, 2020   48,200,929        
Ending balance at Mar. 31, 2020 1,690,374 $ 482 2,612,777 188,057 (261) (1,110,681)
Balance (in shares) at Dec. 31, 2019   48,201,941        
Beginning balance at Dec. 31, 2019 1,705,754 $ 482 2,612,425 177,217 (200) (1,084,170)
Increase (Decrease) in Shareholders' Equity            
Net current period other comprehensive income (loss) 200          
Net income (loss) 8,342          
Balance (in shares) at Sep. 30, 2020   48,318,366        
Ending balance at Sep. 30, 2020 1,636,672 $ 483 2,614,346 185,559 0 (1,163,716)
Balance (in shares) at Mar. 31, 2020   48,200,929        
Beginning balance at Mar. 31, 2020 1,690,374 $ 482 2,612,777 188,057 (261) (1,110,681)
Increase (Decrease) in Shareholders' Equity            
Share grants (in shares)   28,000        
Share grants 1,121   1,121      
Share repurchases (in shares)   (1,129)        
Share repurchases (30)   (30)      
Net current period other comprehensive income (loss) 176       176  
Net income (loss) 1,299     1,299    
Distributions to common shareholders (26,510)         (26,510)
Balance (in shares) at Jun. 30, 2020   48,227,800        
Ending balance at Jun. 30, 2020 1,666,430 $ 482 2,613,868 189,356 (85) (1,137,191)
Increase (Decrease) in Shareholders' Equity            
Share grants (in shares)   108,600        
Share grants 865 $ 1 864      
Share repurchases (in shares)   (18,034)        
Share repurchases (386)   (386)      
Net current period other comprehensive income (loss) 85       85  
Net income (loss) (3,797)     (3,797)    
Distributions to common shareholders (26,525)         (26,525)
Balance (in shares) at Sep. 30, 2020   48,318,366        
Ending balance at Sep. 30, 2020 1,636,672 $ 483 2,614,346 185,559 $ 0 (1,163,716)
Balance (in shares) at Dec. 31, 2020   48,318,366        
Beginning balance at Dec. 31, 2020 1,609,392 $ 483 2,615,305 183,895   (1,190,291)
Increase (Decrease) in Shareholders' Equity            
Share grants 321   321      
Net income (loss) 37,860     37,860    
Distributions to common shareholders (26,575)         (26,575)
Balance (in shares) at Mar. 31, 2021   48,318,366        
Ending balance at Mar. 31, 2021 1,620,998 $ 483 2,615,626 221,755   (1,216,866)
Balance (in shares) at Dec. 31, 2020   48,318,366        
Beginning balance at Dec. 31, 2020 $ 1,609,392 $ 483 2,615,305 183,895   (1,190,291)
Increase (Decrease) in Shareholders' Equity            
Share repurchases (in shares) (37,542)          
Net current period other comprehensive income (loss) $ 0          
Net income (loss) (25,125)          
Balance (in shares) at Sep. 30, 2021   48,425,924        
Ending balance at Sep. 30, 2021 1,505,980 $ 484 2,616,751 158,770   (1,270,025)
Balance (in shares) at Mar. 31, 2021   48,318,366        
Beginning balance at Mar. 31, 2021 1,620,998 $ 483 2,615,626 221,755   (1,216,866)
Increase (Decrease) in Shareholders' Equity            
Share grants (in shares)   28,000        
Share grants 1,176   1,176      
Share repurchases (in shares)   (12,009)        
Share repurchases (352)   (352)      
Net income (loss) (66,697)     (66,697)    
Distributions to common shareholders (26,575)         (26,575)
Balance (in shares) at Jun. 30, 2021   48,334,357        
Ending balance at Jun. 30, 2021 1,528,550 $ 483 2,616,450 155,058   (1,243,441)
Increase (Decrease) in Shareholders' Equity            
Share grants (in shares)   117,800        
Share grants $ 951 $ 1 950      
Share repurchases (in shares) (25,533) (26,233)        
Share repurchases $ (649)   (649)      
Net current period other comprehensive income (loss) 0          
Net income (loss) 3,712     3,712    
Distributions to common shareholders (26,584)         (26,584)
Balance (in shares) at Sep. 30, 2021   48,425,924        
Ending balance at Sep. 30, 2021 $ 1,505,980 $ 484 $ 2,616,751 $ 158,770   $ (1,270,025)